probucol


Also found in: Dictionary, Wikipedia.
Related to probucol: Lorelco

probucol

 [pro´bu-kol]
a bis-phenol compound used as an anticholesteremic; taken orally.

probucol

Lorelco® Cardiology A hypocholesterolemic with antioxidant activity, that ↓ restenosis after balloon angioplasty. See Balloon angioplasty.

probucol

(prō′bū-kōl)
An antihypercholesteremic drug.

probucol (prōbyəkol´),

n brand names: Bifenabid, Lesterol, Lorelco, Lurselle, Superlipid;
drug class: antihyperlipidemic;
action: increases bile acid excretion, catabolism of low-density lipoprotein (LDL) cholesterol; may block oxidation of LDL cholesterol;
use: severe hypercholesterolemia when other treatment is unsuccessful.
References in periodicals archive ?
Although the statistical analyses have suggested overall significance of antioxidant therapy in some studies, only those trials using probucol with or without antioxidant vitamins showed significant effect (Tardif et al.
The most evident biochemical consequence of probucol treatment thus is a CETP-mediated reduction in HDL-C concentration, which some authors have also attributed in part to inhibition of ATP-binding cassette transporter 1 (ABCA1)-mediated HDL biogenesis.
Pro-atherogenic and anti-atherogenic effects of probucol and phytosterols in apo E deficient mice: possible mechanisms of action.
The TSAR stent's rough coating enables it to be coated directly with the anti-restenosis drug rapamycin and the antioxidant probucol.
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.
Medicamentos antilipemicos dispensados con sus dosis respectivas: a) estatinas (lovastatina, atorvastatina, fluvastatina, pravastatina, simvastatina); b) fibratos (gemfibrozil, bezafibrato, etofibrato, fenofibrato); c) resinas fijadoras de acidos biliares (colestiramina), y d) otros (ezetimibe, probucol, acido nicotinico).
Probucol is a modestly potent LDL-lowering agent with powerful anti-oxidant properties that effectively inhibits the oxidative modification of LDL independent of its lipid lowering effect and also inhibits VCAM-1 and MCP-1 expression and inhibits human aortic SMC proliferation as well as atherogenesis (74).
Succinobucol, a potent lipophilic antioxidant, is the monosuccinic acid ester of probucol.
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
The clinical studies have included short and long-term, placebo-controlled and comparative studies versus statins, fibrates, acipimox and probucol.
Ejemplo de esto, el probucol, un reconocido agente antioxidante, que disminuiria, a dosis bajas, los niveles de transaminasas en pacientes con EHGNA.